Researchers close in on cause of gynecological disease

Key points
- For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.
- In a two-step process, a team led by Michigan State University’s Jae-Wook Jeong first identified a protein known as beta-catenin that may play a key role in the development of the disease.
- Then Jeong, an associate professor in the College of Human Medicine’s Department of Obstetrics, Gynecology and Reproductive Biology, created a mouse model that may reveal useful targets for new treatments.
- “Progress in the understanding what causes adenomyosis and finding potential drug treatments has been hampered by the lack of defined molecular mechanisms and animal models,” Jeong said.
For the first time, researchers have created a model that could help unlock what causes adenomyosis, a common gynecological disease that is a major contributor to women having to undergo hysterectomies.
In a two-step process, a team led by Michigan State University’s Jae-Wook Jeong first identified a protein known as beta-catenin that may play a key role in the development of the disease. When activated, beta-catenin causes changes in certain cells in a woman’s uterus, leading to adenomyosis.
Then Jeong, an associate professor in the College of Human Medicine’s Department of Obstetrics, Gynecology and Reproductive Biology, created a mouse model that may reveal useful targets for new treatments.
“Progress in the understanding what causes adenomyosis and finding potential drug treatments has been hampered by the lack of defined molecular mechanisms and animal models,” Jeong said.
“These findings provide great insights into our understanding of the beta-catenin protein and will lead to the translation of animal models for the development of new therapeutic approaches.”
The disease occurs when the inner lining of the uterus (endometrium) breaks through the muscle wall of the uterus (myometrium). Symptoms of the disease include menstrual bleeding, chronic pelvic pain and infertility. Most women with the disease require surgery, and 66 percent of hysterectomies are associated with it.
“This research offers hope to the millions of women who have adenomyosis and holds promise that a cure, besides hysterectomy, is on the horizon,” said Richard Leach, chairperson of the Department of Obstetrics, Gynecology and Reproductive Biology.
The research results were recently published in the Journal of Pathology. The work was supported by grants from the National Institutes of Health, American Cancer Society and World Class University Program at Seoul National University in South Korea.
Leach added the study highlights the groundbreaking research being done in collaboration with other internationally renowned research centers in women’s health.
###
Contact(s): Jason Cody
Media Communications office: (517) 432-0924 cell: (734) 755-0210 [email protected]
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Women's Health →
NewsAntioxidants Cause Fertility Problems in Females
Antioxidants are sold over the counter everywhere. They’re added to food, drink and face cream. But according to Prof. Nava Dekel of the Biological Regulation Department, we still don’t have a complete understanding of…
19 January 2011
NewsOutpatient Care Underused in Treatment of Teens with Pelvic Inflammatory Disease
Hospitalizing teen girls with pelvic inflammatory disease (PID) costs six times as much as treating them in the emergency room, and up to 12 times more than treating them in an outpatient clinic, according to a small…
6 January 2011
NewsAromatase inhibitors increased risk of heart disease in postmenopausal women with breast cancer
Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis. These data, presented…






